TD Cowen reiterated its hold rating and price target for agilon health, inc., while also upgrading the rating based on market performance.
1 report, 1 independent
Updated Jun 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen reiterated its hold rating and price target for agilon health, inc., while also upgrading the rating based on market performance.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
TD Cowen
American investment bank
-
Jefferies Financial Group
American financial services company
Related events
- TD Cowen maintained and revised ratings and price targets for several fintech companies including Klarna, SoFi, Sezzle, Capital One, and Affirm.
- TD Cowen, Stephens, Citigroup, and MarketBeat provided new analyst ratings and coverage for Covenant Logistics Group, Inc.
- TD Cowen issued a buy rating and price target for Dexcom on October 9, 2026.
- TD Cowen increased its target price to $3.00, while Jefferies Financial Group was involved in a rating update for Plug Power, with MarketBeat aggregating the consensus data.
- TD Cowen raised its price target and gave a buy rating for Travere Therapeutics, Inc., while various institutional investors bought into the company.